0:00
43:47
Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashes guidance. So are the disappointing results a sign the weight loss drug boom is slimming out?
More episodes from "CNBC's "Fast Money""
Don't miss an episode of “CNBC's "Fast Money"” and subscribe to it in the GetPodcast app.